Status:
UNKNOWN
Long Non Coding RNA HOTAIR and Midkine as Biomarkers in Thyroid Cancer
Lead Sponsor:
Assiut University
Conditions:
Thyroid Cancer
Eligibility:
All Genders
20+ years
Brief Summary
Thyroid cancer is the most prevalent endocrine malignancy.Papillary thyroid carcinomas and follicular thyroid carcinomas account for 95% of all thyroid cancer cases. They are clinically classified as ...
Detailed Description
Thyroid cancer is the most prevalent endocrine malignancy.Papillary thyroid carcinomas and follicular thyroid carcinomas account for 95% of all thyroid cancer cases. They are clinically classified as ...
Eligibility Criteria
Inclusion
- patient with thyroid mass
Exclusion
- no other known organ malignancy no previous chemotherapy
Key Trial Info
Start Date :
March 29 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 29 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03469544
Start Date
March 29 2018
End Date
March 29 2020
Last Update
March 19 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.